Cell and gene therapies, which involve the transfer of genetic material or cells into a patient for treatment, have been on ...

Viatris shares fell to a 52-week low after the drug company said issues related to a India facility are expected to hurt 2025 total revenue by about $500 million. The stock was recently down 14% to $9 ...

The rule would prevent many cereal and yogurt products from making nutrition claims and allow nuts, oils and certain seafood ...

Leadership in statistical programming is about more than managing deliverables—it’s about inspiring teams and exceeding ...

India's drug regulator plans to streamline export clearances and simplify manufacturing licensing to reduce workforce burden.

Follow President Donald Trump's executive order, the Department of Health and Human Services issued new guidance that ...

India's drug regulator aims to implement various reforms, including streamlining export clearances for unapproved drugs and ...

Robert F. Kennedy Jr, the newly confirmed health secretary for the Trump administration who has called for sweeping policy ...

Aurinia Pharmaceuticals reported Q4 earnings of 1 cent per share, beating estimates, with LUPKYNIS sales up 36%.

Vietnam is aiming to attract overseas investment to encourage domestic drug development through the amended 2016 Law on ...

Novartis' dividend yield currently stands at 3.58%, which is significantly higher than that of the healthcare sector. Read ...

Life-saving programs, including George W. Bush’s cherished global AIDS initiative, were hit in the latest, harshest round of ...